Plasma visfatin and apelin levels in adolescents with polycystic ovary syndrome.

Xiangyan RuanMeng LiMin MinRui JuHusheng WangZhongting XuSuiyu LuoAlfred Otto Mueck

Published in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2023)

Higher visfatin levels may prevent IR in adolescent PCOS patients, showing a positive predictive value for IR and also reflecting a beneficial effect on lipids. It is a possible protective factor at certain stages of metabolic syndrome.

Keyphrases

metabolic syndrome
young adults
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
physical activity
fatty acid
cardiovascular disease
adipose tissue
cardiovascular risk factors